June 27, 2026 02:56 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Pune fort murder case: Siya Goyal's brother says family would have called off marriage if she had objected | Donald Trump gets a road named after him in India, says 'Thank You!' | Fresh setback for Gautam Adani? US judge asks DoJ to justify dropping criminal charges | Ram Mandir Trust chief Champat Rai resigns as alleged donation siphoning row escalates | Ram Mandir fund row deepens: 8 arrested days after BJP called allegations 'false narrative' | 'Who tied the hands of CBI?': Calcutta HC on RG Kar case; victim's mother, now BJP MLA, says she is 'deeply disturbed' | Construction comes to a standstill at nearly 700 Kolkata projects after Taratala warehouse tragedy kills 15 | World Cup shocker! Ecuador stun Germany 2-1, storm into Round of 32 | Iran-US conflict: Cargo vessel hit near Strait of Hormuz, UN agency pauses evacuation operations | Amazon's massive India bet! Andy Jassy announces $48 billion investment after meeting PM Modi
Adar Poonawalla
Adar Poonawalla Twitter page

Will take 4-5 years until everyone gets COVID-19 vaccine, says Serum Institute of India CEO Adar Poonawalla 

| @indiablooms | Sep 14, 2020, at 11:40 pm

Pune: Adar Poonawalla, chief executive of the Serum Institute of India, has said it will take four to five years until everyone gets the COVID-19 vaccine on this planet.

He told the Financial Times that pharmaceutical companies were not increasing production capacity quickly enough to vaccinate the global population in less time.

“It’s going to take four to five years until everyone gets the vaccine on this planet,” said Poonawalla, who estimated that if the Covid-19 shot is a two-dose vaccine — such as measles or rotavirus — the world will need 15bn doses.  

Based in the western Indian city of Pune, the family-run Serum Institute has partnered with five international pharmaceutical firms, including AstraZeneca and Novavax, to develop a Covid-19 vaccine and committed to produce 1bn doses, of which it has pledged half to India. The company may also partner with Russia’s Gamaleya Research Institute to manufacture the Sputnik vaccine, reports the newspaper.

India is one of the nations in the world that has registered a high number of COVID-19 cases for the past several months.

The virus is believed to have originated from China.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.